Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients
Abstract Background To improve identification of patients with cutaneous squamous cell carcinoma (SCC) at high risk for metastatic disease, the DecisionDx-SCC assay, a prognostic 40-gene expression profile (40-GEP) test, was developed and validated. The 40-GEP assay utilizes RT-PCR gene expression a...
Saved in:
Main Authors: | Sherri Borman (Author), Jeff Wilkinson (Author), Lauren Meldi-Sholl (Author), Clare Johnson (Author), Kelsey Carter (Author), Kyle R. Covington (Author), Alison L. Fitzgerald (Author), Sarah J. Kurley (Author), Aaron S. Farberg (Author), Matthew S. Goldberg (Author), Federico A. Monzon (Author), Kristen Oelschlager (Author), Robert W. Cook (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients
by: Robert W. Cook, et al.
Published: (2018) -
Computed Tomographic findings of maxillofacial SCC and Undifferentiated carcinoma
by: Adineh Javadian Langaroodi, et al.
Published: (2015) -
Expression of VEGF in the normal and dysplastic mucous membranes and SCC using immunohistochemistry
by: Sayed Mohammad Razavi, et al.
Published: (2012) -
Incorporation of the 40-Gene Expression Profile (40-GEP) Test to Improve Treatment Decisions in High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients: Case Series and Algorithm
by: Singh G, et al.
Published: (2023) -
The Role of TROP2 in BCC and Cutaneous SCC: A Clinical and Immunohistochemical Study
by: Farag AGA, et al.
Published: (2021)